Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06156397 | The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery | completed | N/A | 45 | Medipol UniversityOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06340503 | Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors | completed | N/A | 20 | Wake Forest University Health SciencesOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06534957 | Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy | completed | N/A | 128 | Medicos e Investigadores en la Lucha contra el Cancer de MamaOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT01750073 | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer | completed | Phase 2 | 92 | University of NebraskaOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT01805076 | MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer | completed | Phase 3 | 319 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT03323346 | Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer(DISC) | completed | Phase 2 | 9 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT05203497 | Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2 | completed | Phase 1 | 30 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT05940298 | Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 | completed | Phase 1 | 10 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT06096623 | The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment | completed | — | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT02206334 | Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 1 | 42 | NRG OncologyOTHER | 3 | Jun 25, 2026 | clinicaltrials |
| NCT03271476 | EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient(PSYCANCER) | completed | N/A | 15 | Centre Hospitalier Régional Metz-ThionvilleOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT03326713 | Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project(GRACE) | completed | N/A | 668 | Rutgers, The State University of New JerseyOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT05185947 | Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06791018 | Cancer Exercise: Evaluation of a Mobile App in Breast Cancer Survivors | completed | N/A | 132 | University of AlbertaOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07668076 | The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients | completed | Phase 2 | 44 | Damanhour UniversityOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07669506 | A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy(NuvastaticTM) | completed | Phase 3 | 180 | Natureceuticals Sdn BhdINDUSTRY | 1 | Jun 25, 2026 | clinicaltrials |
| NCT03991260 | 99mTc-ADAPT6-based HER2 Imaging in Breast Cancer(99mTc-ADAPT6) | completed | — | 16 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT04277338 | Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3(HE3-G3) | completed | Phase 1 | 30 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT04817501 | Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System(CTCs) | completed | — | 150 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05412446 | 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes(99mTc-ADAPT6) | completed | Phase 2 | 30 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05412459 | 99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy | completed | — | 15 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05695859 | 99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy | completed | — | 24 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT06874985 | Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation | completed | N/A | 1,264 | International Agency for Research on CancerOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07666724 | Oncology Treatment Related Ocular Surface Changes(23AA01) | completed | — | 35 | Semmelweis UniversityOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT00785291 | Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer | completed | Phase 3 | 799 | National Cancer Institute (NCI)NIH | 2 | Jun 23, 2026 | clinicaltrials |
| NCT02792465 | A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors | completed | Phase 1 | 52 | University Health Network, TorontoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT04456920 | Pain Monitoring After Breast Biopsy: Benefit of E-health(BIO-PSY) | completed | N/A | 193 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05297773 | Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment(NEO-Program) | completed | N/A | 132 | Fundacao ChampalimaudOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07068477 | Adaptation of a Values Assessment Tool | completed | N/A | 67 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT02926547 | New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement | completed | — | 108 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT05269186 | Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy(REAVA) | completed | N/A | 256 | Centre Hospitalier Departemental VendeeOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT05708950 | A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | completed | Phase 1 / Phase 2 | 40 | Kineta Inc.INDUSTRY | 1 | Jun 18, 2026 | clinicaltrials |
| NCT06006299 | Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) | completed | Phase 1 | 20 | University of Alabama at BirminghamOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT03213041 | Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer | completed | Phase 2 | 12 | Northwestern UniversityOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT01730833 | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer | completed | Phase 2 | 63 | City of Hope Medical CenterOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07651020 | The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors | completed | — | 1 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT04737265 | Pilot Study of an NTproBNP Guided Strategy of Cardioprotection(NTproBNP-Guide) | completed | Phase 1 / Phase 2 | 108 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT05030038 | Oral Aromatase Inhibitors Modify the Gut Microbiome | completed | — | 24 | Wake Forest University Health SciencesOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07108959 | ESPB Versus Perioperative Iv Lidocaine Infusion on Proinflammatory Cytokines in Breast Cancer Surgeries(ESPB) | completed | N/A | 40 | Alexandria UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07647042 | A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 Inhibitors(LEEWARD) | completed | — | 750 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07648940 | Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients | completed | Phase 1 | 74 | Zodiac Produtos Farmaceuticos S.A.INDUSTRY | 1 | Jun 15, 2026 | clinicaltrials |
| NCT01556243 | Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | completed | Phase 2 | 270 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03107234 | Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers(CarcIno) | completed | — | 42 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05301998 | Tridimensional Geometric Modeling of the Breast(SENO 3D) | completed | N/A | 200 | University Hospital, MontpellierOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07644858 | MammoVerse: Breast Cancer Sexual Health Focus Groups | completed | — | 24 | University of Central FloridaOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05303129 | Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.(PEPSI) | completed | N/A | 165 | Centre Francois BaclesseOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06035731 | Evaluation of the Medical Service by Socio-aesthetics in Oncology(RCT-SE) | completed | N/A | 400 | Centre Hospitalier de ValenceOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07641114 | Behavior Change Wheel-Based Music Listening for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients(BCW-MUSIC) | completed | N/A | 90 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT02392845 | A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study(MODEL1) | completed | Phase 1 | 17 | Hospices Civils de LyonOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT04937660 | Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC(PRECIOUS) | completed | — | 185 | PfizerINDUSTRY | 5 | Jun 10, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 29, 2026source: clinicaltrials